BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24272282)

  • 1. The role of F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET/CT) in the screening of cervical cancer: a literature review.
    Guo F; Yang R; Tian J; Fan L
    Cell Biochem Biophys; 2014 Jun; 69(2):197-201. PubMed ID: 24272282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.
    Liu FY; Yen TC; Chen MY; Lai CH; Chang TC; Chou HH; Hong JH; Chen YR; Ng KK
    Cancer; 2009 Dec; 115(23):5470-80. PubMed ID: 19739235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
    Lv K; Guo HM; Lu YJ; Wu ZX; Zhang K; Han JK
    Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
    Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.
    Chao A; Ho KC; Wang CC; Cheng HH; Lin G; Yen TC; Lai CH
    Gynecol Oncol; 2008 Aug; 110(2):172-8. PubMed ID: 18499238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
    Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
    Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
    Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
    Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
    J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
    Ouyang L; Shi ZY; Lin ZG
    Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of ¹⁸F-FDG PET/CT in the pretreatment evaluation of patients with locally advanced cervical carcinoma.
    Akkas BE; Demirel BB; Vural GU
    Nucl Med Commun; 2012 Oct; 33(10):1081-8. PubMed ID: 22926065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
    Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic response of lymph nodes immediately after RT is related with survival outcome of patients with pelvic node-positive cervical cancer using consecutive [18F]fluorodeoxyglucose-positron emission tomography/computed tomography.
    Yoon MS; Ahn SJ; Nah BS; Chung WK; Song HC; Yoo SW; Song JY; Jeong JU; Nam TK
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e491-7. PubMed ID: 22818418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The accuracy of FDG-PET/CT in early-stage cervical and vaginal cancers].
    Bentivegna E; Uzan C; Gouy S; Leboulleux S; Duvillard P; Lumbroso J; Haie-Meder C; Morice P
    Gynecol Obstet Fertil; 2011 Apr; 39(4):193-7. PubMed ID: 21429783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.
    Yen TC; Ng KK; Ma SY; Chou HH; Tsai CS; Hsueh S; Chang TC; Hong JH; See LC; Lin WJ; Chen JT; Huang KG; Lui KW; Lai CH
    J Clin Oncol; 2003 Oct; 21(19):3651-8. PubMed ID: 14512397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT of cervical carcinoma.
    Patel CN; Nazir SA; Khan Z; Gleeson FV; Bradley KM
    AJR Am J Roentgenol; 2011 May; 196(5):1225-33. PubMed ID: 21512096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.